INFU

Business Context and Reporting Period

Company: Infusystem Holdings, Inc. (formerly HAPC, Inc.)
Filing Type: Form 10-Q (Unaudited)
Period Ended: September 30, 2007
Status: The Company was a "blank check" corporation in the development stage formed to acquire a healthcare business. As of the filing date, it had not yet consummated its business combination, though a definitive agreement was in place to acquire InfuSystem, Inc. from I-Flow Corporation. The acquisition was subsequently consummated on October 25, 2007.

Key Financial Metrics

Cash Flow (Nine Months Ended Sep 30, 2007):
- Net cash used in operating activities: $(661,886)
- Net cash used in investing activities: $(251,805)
- Net cash provided by financing activities: $513,500

Material Changes vs. Prior Period

• Stock-Based Compensation: Compensation expense decreased significantly to $263,595 for the three months ended September 30, 2007, compared to $14,192,236 in the same period in 2006. The 2006 figure included a one-time charge of approximately $13 million related to the vesting of shares reserved for directors.
• Warrant Liability Volatility: The Company recorded a non-cash loss on warrant liabilities of $675,010 for the nine months ended September 30, 2007, compared to a non-cash gain of $9,450,140 in the prior year period. This fluctuation is due to changes in the fair market value of the warrants.
• Ticking Fees: The Company incurred a "ticking fee" of $543,749 for the nine months ended September 30, 2007, related to the pending acquisition of InfuSystem. No such fee was incurred in the comparable 2006 period.
• Liquidity: Cash and cash equivalents outside the trust account decreased from $427,372 at December 31, 2006, to $27,181 at September 30, 2007, primarily due to the payment of acquisition-related expenses.

Outlook, Risks, and Unusual Items

• Acquisition Status: The Company entered into a Stock Purchase Agreement to acquire InfuSystem, Inc. for $100 million. The transaction closed on October 25, 2007, shortly after the reporting period. The purchase price included a promissory note and cash from the trust account.
• Contingent Consideration: The acquisition agreement includes an earn-out provision allowing for an additional payment of up to $12 million to I-Flow in 2011, contingent upon achieving specific revenue growth targets (CAGR of 40% to 50%).
• Termination Fee: A $3 million termination fee was agreed upon and subsequently paid upon the closing of the acquisition. This fee was guaranteed by the Company's Chairman and another director.
• Material Weakness in Internal Controls: Management identified a material weakness in financial reporting controls due to insufficient resources to evaluate complex transactions, specifically regarding the accounting for warrant liabilities. Remedial actions were underway as of the filing date.
• Shareholder Conversions: Approximately 2.7 million shares were converted to cash by shareholders voting against the acquisition, reducing the trust account balance available for the transaction.

Investor Verification Checklist

• Acquisition Closing: Verify the final terms of the InfuSystem acquisition closed on October 25, 2007, including the exact cash and debt components of the $100 million purchase price.
• Warrant Liability Valuation: Confirm the fair value of the 33.75 million outstanding warrants, as fluctuations in this liability significantly impact reported net income/loss.
• Trust Account Disbursement: Review the final allocation of the $101.2 million trust account, including payments to I-Flow, shareholder redemptions, and transaction fees.
• Internal Control Remediation: Assess the progress of remedial actions taken to address the material weakness in financial reporting controls identified in the filing.
• Earn-Out Potential: Monitor future revenue reports to determine if the Company will be required to pay the contingent $12 million earn-out to I-Flow in 2011.